Medical Weight Loss for Rapid City, South Dakota Residents

Rapid City, South Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Rapid City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Rapid City? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in South Dakota. Doctor review just $119 (medication separate).

Why Rapid City Residents Choose New Hope Weight Loss

You never have to leave Rapid City to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in South Dakota. Whether you live near Downtown, the greater Rapid City area, and the Black Hills region or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

If you are searching for medical weight loss in Rapid City, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Whether you are near downtown Rapid City or somewhere quieter in South Dakota, the same doctor-supervised plan runs over telehealth, with our only physical location remaining in Costa Mesa, California. We care for patients throughout Downtown, the greater Rapid City area, and the Black Hills region. You can have your first video visit from your kitchen in Rapid City and have your treatment plan in motion the same week.

Distance simply stops mattering here, since every appointment for Rapid City residents takes place over secure video rather than in a waiting room. We accept HSA and FSA cards for the $119 physician review, which lets many Rapid City patients use pre-tax dollars toward their care. In a state as spread out as South Dakota, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never stands in the way of care.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Rapid City patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Rapid City

Getting started in Rapid City is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, usually within 48 hours, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, a state-licensed 503(a) pharmacy ships your medication straight to your Rapid City address in cold-pack packaging that keeps it stable in transit. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in you live.

Frequently Asked Questions, Rapid City

Where is the closest New Hope Weight Loss to Rapid City?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Rapid City, South Dakota patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Rapid City?

It is not. We run a complete telehealth model, so people in Rapid City handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Rapid City using cold-pack insulation that keeps it stable until it reaches you.

What should a Rapid City patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Rapid City patients are not charged any extra distance fee.

What areas of Rapid City do you serve?

We serve patients from across Rapid City by telehealth, including Downtown, the greater Rapid City area, and the Black Hills region.

How does telehealth treatment work for Rapid City patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Rapid City address. Follow-ups also happen by video.

Rapid City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Rapid City, South Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.